Provided by Tiger Trade Technology Pte. Ltd.

Viridian Therapeutics, Inc.

31.60
-0.5300-1.65%
Post-market: 31.600.00000.00%17:48 EST
Volume:1.55M
Turnover:49.13M
Market Cap:3.02B
PE:-10.46
High:32.27
Open:32.15
Low:31.20
Close:32.13
52wk High:34.04
52wk Low:9.90
Shares:95.44M
Float Shares:80.72M
Volume Ratio:1.14
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0205
EPS(LYR):-3.0722
ROE:-49.89%
ROA:-30.08%
PB:9.60
PE(LYR):-10.29

Loading ...

Viridian Therapeutics Inc : Wedbush Raises Target Price to $47 From $42

THOMSON REUTERS
·
Dec 10

Evaluating Viridian Therapeutics (VRDN) After William Blair’s New ‘Outperform’ Rating and Rising Investor Optimism

Simply Wall St.
·
Dec 06

BRIEF-Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Dec 05

Viridian Therapeutics Grants Stock Options to New Employees as Inducement Awards

Reuters
·
Dec 05

Will William Blair’s Outperform Initiation Shift Viridian Therapeutics’ (VRDN) Narrative Among Institutional Investors?

Simply Wall St.
·
Dec 04

Viridian Therapeutics Inc : William Blair Initiates Coverage With Outperform Rating

THOMSON REUTERS
·
Dec 03

Exploring 3 High Growth Tech Stocks in the US Market

Simply Wall St.
·
Nov 25

Truist Financial Initiates a Buy Rating on Viridian Therapeutics (VRDN)

TIPRANKS
·
Nov 24

H.C. Wainwright Sticks to Their Buy Rating for Viridian Therapeutics (VRDN)

TIPRANKS
·
Nov 10

Viridian Therapeutics Grants Stock Options to New Employees

Reuters
·
Nov 07

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Nov 07

Viridian Therapeutics Up Over 14%, on Track for Highest Close Since May 2023 -- Data Talk

Dow Jones
·
Nov 07

H.C. Wainwright Keeps Their Buy Rating on Viridian Therapeutics (VRDN)

TIPRANKS
·
Nov 06

Viridian Therapeutics Secures $889 Million Financing and Submits BLA for Veligrotug

Reuters
·
Nov 05

BRIEF-Viridian Therapeutics Q3 Net Income USD -34.599 Million

Reuters
·
Nov 05

Viridian Therapeutics Q3 Revenue USD 70 Million VS. Ibes Estimate USD 40.3 Thousand

THOMSON REUTERS
·
Nov 05

Viridian Therapeutics Inc - Cash Position About $887.9 Mln as of Oct 31, 2025

THOMSON REUTERS
·
Nov 05

Press Release: Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

Dow Jones
·
Nov 05

Viridian Therapeutics submits BLA to the FDA for veligrotug

TIPRANKS
·
Nov 03

Viridian Therapeutics Submits BLA to FDA for Veligrotug in Thyroid Eye Disease

Reuters
·
Nov 03